Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hippocampal Dhcr24 Down Regulation in a Rat Model of Streptozotocin-Induced Cognitive Decline Publisher Pubmed



Hosseinzadeh S1 ; Zahmatkesh M1 ; Heidari M2 ; Hassanzadeh GR1, 3 ; Karimian M1, 4 ; Sarrafnejad A5 ; Zarrindast MR1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Neuroscience Letters Published:2015


Abstract

The DHCR24 (24-dehydrocholesterol reductase) gene codes a multifunctional protein which consists of enzymatic, antioxidant, and anti-apoptotic activities. It exists in almost all neurons and protects the neural cells against amyloid β toxicity. Several studies have shown the down regulation of DHCR24 in Alzheimer's disease. We examined the time profile of DHCR24-mRNA alteration in an animal model of streptozotocin (STZ)-induced cognitive impairment. The DHCR24 mRNA levels of hippocampus and cognitive impairment were evaluated at 7, 14, and 21 days after intracerebroventricular (ICV)-STZ/Saline administration. DHCR24 expression was down regulated at 14 and 21 days after ICV-STZ administration. The decrease in expression of DHCR24 preceded the onset of the cognitive impairment. These results suggest the potential relation between DHCR24 expression and cognitive impairment. © 2014 Elsevier Ireland Ltd.
Experts (# of related papers)
Other Related Docs